Curated News
By: NewsRamp Editorial Staff
August 11, 2026
Synbio International Launches Healing Force™ Nutraceutical Division
TLDR
- Synbio International launches Healing Force Anxiety Relief, entering the $684B nutraceutical market, aiming for a first-mover advantage.
- Synbio International begins commercial operations with Healing Force nutraceuticals, bypassing lengthy approvals to rapidly generate revenue via direct-to-consumer online sales.
- Healing Force Anxiety Relief offers a natural, non-pharmaceutical option to support mental wellness, addressing growing consumer demand for preventive health solutions.
- Synbio International, known for AI mental health screening, diversifies into nutraceuticals, capitalizing on a market projected to reach $1.1 trillion by 2033.
Impact - Why it Matters
This news matters because it signals Synbio International's shift from a development-stage company to one with actual revenue-generating products. For investors, it represents a potential inflection point in the company's financial trajectory, offering a tangible product that can generate near-term cash flow while the company continues to develop its AI-driven mental health technology. For consumers, it introduces a new natural wellness option for anxiety relief, tapping into the growing demand for non-pharmaceutical approaches to mental health. The dual-track strategy of combining nutraceutical sales with advanced medical technology validation could provide a model for other companies in the health and wellness space, demonstrating how to balance immediate market opportunities with long-term innovation.
Summary
Synbio International, Inc. (OTC: SYIN) has officially transitioned from a development-stage company to an operating business with the launch of its Healing Force™ nutraceutical division and first consumer product, Healing Force™ Anxiety Relief. This natural wellness formulation is designed to support individuals seeking non-pharmaceutical approaches to managing everyday stress and anxiety. The launch marks a significant milestone in the company's evolution, as it begins executing its revenue generation strategy through commercial operations. By leveraging the nutraceutical market, which is expected to grow from approximately US$684 billion to over US$1.1 trillion by 2033, Synbio aims to capitalize on the increasing consumer demand for preventative healthcare and natural wellness products.
CEO Claudio Solitario emphasized that this launch is more than just a product; it represents the company's transition into an operating entity and the beginning of a strategy to create sustainable long-term shareholder value through multiple revenue streams. The Healing Force™ product line has been developed under the guidance of Dr. David Anderson, M.D., who brings decades of experience in nutraceutical research and development. The company plans to initially market and distribute products through direct-to-consumer online channels to maximize capital efficiency and scale rapidly. Synbio continues to advance its healthcare technology initiatives, including the validation of the FacialDx Inc. facial analysis platform for mental health, balancing near-term commercial opportunities with long-term technology development. This dual-track strategy positions the company to generate revenue while building a diversified wellness and healthcare platform.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Synbio International Launches Healing Force™ Nutraceutical Division
